CTRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CTRI is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 available. The business fundamentals and Q1 results are improving, but the stock just had a sharp market reaction and is sitting near support rather than in a clean entry zone. Since there is no AI Stock Picker or SwingMax buy signal today, I would not call this a strong immediate buy; I would wait or only consider a small starter position after confirmation of stability.
CTRI shows a mixed-to-neutral technical setup. The 5/20/200-day moving averages are bullishly aligned, which supports the longer-term trend. MACD histogram is positive but contracting, suggesting momentum is fading rather than accelerating. RSI_6 at 33.3 is near oversold but not strongly oversold. Price at 33.61 is essentially at S1 support 33.634, while pivot resistance is 37.632, so the stock is trading near a key floor after a weak session. The similar-pattern model also points to downside drift over the next day, week, and month, which reduces urgency to buy immediately.
Q1 earnings were strong: EPS beat by $0.04, revenue rose 31.5% year over year to $723.2 million, gross profit increased 76%, and the company won over $345 million in new customer awards. For the prior quarter, revenue grew 19.74% YoY, net income rose 193.04% YoY, and EPS rose 166.67% YoY, showing clear operating improvement. Analysts at Cantor Fitzgerald and Baird raised price targets after better-than-expected results, and both kept constructive ratings. The longer-term moving average structure remains bullish.
The stock had a very sharp negative market move in the latest session despite the positive earnings/news backdrop, showing the market is still skeptical or reacting to a specific risk factor. Wells Fargo reduced its target to $32 and highlighted uncertainty around sentiment. JPMorgan remains Underweight, and BofA is still Underperform despite a higher target, signaling Wall Street is not uniformly bullish. Gross margin in the latest financial snapshot fell 5.12% year over year, which tempers the growth story. No significant hedge fund, insider, or congress buying support was reported recently.
Latest quarter: Q1 2026. Centuri posted revenue of $723.2 million, up 31.5% YoY and well above expectations, with gross profit of $35.8 million up 76% YoY. GAAP EPS was -$0.09, but that still beat estimates by $0.04. In the most recent prior quarter, revenue was $858.6 million, up 19.74% YoY, net income rose 193.04% YoY to $30.18 million, and EPS rose to $0.32, but gross margin declined to 8.53%, down 5.12 percentage points YoY. Overall, growth is strong, but margin pressure remains a point to watch.
Analyst sentiment is moderately positive but not unanimous. Recent actions include Cantor Fitzgerald raising its target twice to $35.25 and then $37.40 with Overweight ratings, and Baird raising its target to $35 with an Outperform rating after strong Q4 results. However, Wells Fargo cut its target to $32 while keeping Overweight, JPMorgan remains Underweight with a $26 target, and BofA is still Underperform despite lifting its target to $28. Wall Street pros appear split: the bullish side likes revenue growth and order momentum, while the cautious side wants more proof on free cash flow, margin durability, and a cleaner growth profile.
